Benzo [a]pyrene diol epoxide (BPDE), the active metabolite of benzo [a]pyrene present in tobacco smoke, is a major cancer-causing compound. To evaluate the effects of BPDE on human breast epithelial cells, we exposed an immortalized human breast cell line, MCF 10A, to BPDE and characterized the gene expression pattern. Of the differential genes expressed, we found consistent activation of DDX3, a member of the DEAD box RNA helicase family. Overexpression of DDX3 in MCF 10A cells induced an epithelial-mesenchymal-like transformation, exhibited increased motility and invasive properties, and formed colonies in soft-agar assays. Besides the altered phenotype, MCF 10A-DDX3 cells repressed E-cadherin expression as demonstrated by both immunoblots and by E-cadherin promoter-reporter assays. In addition, an in vivo association of DDX3 and the E-cadherin promoter was demonstrated by chromatin immunoprecipitation assays. Collectively, these results demonstrate that the activation of DDX3 by BPDE, can promote growth, proliferation and neoplastic transformation of breast epithelial cells.
Introduction
Breast cancer is the second leading cause of cancerrelated deaths in American women (Parkin and Muir, 1992; Sasco, 2001) . The etiology of breast cancer can be associated with a number of factors such as nulliparity, age, hormonal factors, alcohol intake and so on (Norsa'adah et al., 2005; Boffetta et al., 2006; Yager and Davidson, 2006) . However, many of these factors account for less than one-half of all sporadic cases (Phillips et al., 1991) . Thus, it is likely that environmental factors are also involved in the development of breast cancer. A member of a class of environmental pollutants (polycyclic aromatic hydrocarbons) that may contribute to human breast cancer is benzo(a)pyrene (BaP), a major constituent of tobacco smoke (Reynolds et al., 2004) . The highly reactive epoxy metabolite of BaP, benzo [a] pyrene diol epoxide (BPDE), can form stable DNA adducts, for example, within Ha-ras oncogene, and initiate carcinogenesis as shown in human fibroblasts and CHO cell lines (Krolewski et al., 1988; Yang et al., 1992) . Moreover, there is emerging evidence that indicates that human mammary epithelium may be susceptible to carcinogenic transformation upon exposure to BPDE (Mei et al., 2003) . For instance, human mammary epithelial cells and breast cancer cell lines, exposed to BPDE, exhibited altered cell cycle progression, decreased BRCA-1 expression and an increased spectrum of p53 mutations (Jeffy et al., 2002; Pfeifer et al., 2002; Wang et al., 2003; Burdick et al., 2006) . It has also been shown that treating MCF 10A cells with 1 mM of B[a]P for 48 hours is sufficient to cause chromosomal aberrations and induce anchorageindependent growth (Caruso et al., 2001) . This indicates that carcinogens present in tobacco smoke may be a contributing factor in the etiology of breast cancers. Thus, we have initiated studies aimed at characterizing cellular components and pathways, at the molecular level, that are altered during an exposure to BPDE.
In our efforts to understand better the transforming abilities of BPDE, within the context of human breast epithelial cells, we have identified a member of the DEAD box RNA helicase family, DDX3, which is upregulated after exposing immortalized non-tumorigenic breast epithelial cells, MCF 10A, to BPDE. DEAD box RNA helicases have been shown to function in RNA metabolism including translation, ribosome biogenesis, pre-mRNA splicing and nucleo-cytoplasmic RNA transport (Cordin et al., 2006; Linder, 2006) . Besides their role in RNA biogenesis there is now evidence to indicate that DEAD box RNA helicases can participate in the progression of cancer (Abdelhaleem, 2005) . For example, human DDX5 has been shown to be overexpressed at the protein level in colorectal tumors as well as in the hepatic tumor cell lines, HT-29 and HCT116, which have undergone an epithelial-mesenchymal transition (Yang et al., 2005 (Yang et al., , 2006 . In addition, DDX5 has been shown to upregulate the expression of cyclin D1 along with c-myc genes, which promoted cell proliferation in a series of mammalian cell lines (Yang et al., 2007) . Along these lines, the activity of oncoprotein EWS-FLI1 has been shown to be enhanced by RNA helicase H in the Ewing's sarcoma family of tumors (Toretsky et al., 2006) . The X-linked DEAD box RNA helicase, DDX3 has been shown to be upregulated in hepatocellular carcinoma tissues and through its interaction with hepatitis C virus core protein, may be a contributing factor to hepatitis C virus-mediated carcinogenic processes (Owsianka and Patel, 1999; Huang et al., 2004) . However, in another study, DDX3 in hepatocellular carcinoma cell lines was shown to transcriptionally upregulate the tumor suppressor molecule, p21, thus decreasing cell proliferation (Chang et al., 2006; Chao et al., 2006) . Also, DDX3 has been shown to be inactivated in HeLa cells during mitosis via the phosphorylation of Threonine 204 by the cyclinB/cdc2 complex (Sekiguchi et al., 2007) . Thus, the role of DDX3 in cancer biogenesis appears to be divergent and tumor type-dependent.
In this report, we show that the expression of DDX3 is enhanced in the breast epithelial cell line MCF 10A upon exposure to BPDE. Also, stable overexpression of DDX3 in MCF 10A cells induces an epithelialmesenchymal-like transition and promotes aggressive properties such as increased motility and invasion as well as the ability to form colonies in soft agar, which are the characteristic features of cellular transformation. In addition, our data also demonstrate that DDX3 expression downregulates the expression of the cell adhesion molecule E-cadherin, resulting in the translocation of b-catenin into the nucleus. Taken together, we show that overexpression of DDX3 in mammary epithelium can promote breast tumorigenesis.
Results
Effect of BPDE on the growth and viability of MCF 10A cells To identify potential candidate genes induced by BPDE in MCF 10A cells, the optimal concentration of BPDE and its incubation time with cells were determined. The growth ratio and percentage of viable cells were estimated at 3, 10 and 24 h following exposure to increasing concentrations of BPDE (0.5, 1, 1.5, 2, 2.5 and 3 mM). Figure 1a (left panel) indicates that MCF 10A cells exposed to concentrations of BPDE above 0.5 mM showed a continual decline in growth during the 24 h period, with respect to control cultures. However, BPDE concentrations at or below 0.5 mM had little or no affect on cell growth during the 3-and 10-h incubation periods. On the contrary, when the cultures were exposed to 1.5 mM BPDE, cell growth was reduced by approximately 55% during the 10-h period. As shown in Figure 1a (right panel), cell viability remained unaffected at all BPDE concentrations during the initial 3 h. However, very few viable cells remained when cultures were exposed to 1.0 mM BPDE for 24 h. On the basis of this data, MCF 10A cells were incubated with 0.5 mM of BPDE for 3 and 10 h, and RNA was extracted at each time point. Following Affymetrix microarray data analyses, DDX3 was one of the genes that was found to be upregulated approximately fourfold in MCF 10A cells treated with BPDE.
BPDE induces DDX3 expression in mammary epithelial cells Having identified that DDX3 gene expression is induced by BPDE, we proceeded to test the finding at the protein level in MCF 10A and MCF 12A cell lines. Following incubation in 0.5 mM BPDE for 1 h, the cells were washed and replenished with complete medium and incubated for a further 6 h. Total proteins from MCF 10A and MCF 12A cells were then analysed for DDX3 protein levels by immunoblot analysis. As shown in Figure 1b (left panel), DDX3 protein levels increased after 3 h of incubation in BPDE in both cell lines, and continued to increase up to 6 h.
Analysis of DDX3 expression in breast epithelial cell lines
To determine whether the expression of DDX3 correlates with breast cancer invasiveness, we performed immunoblot analyses on total protein preparations from a panel of normal immortalized breast cell lines and breast cancer cell lines with varying degree of invasiveness. Figure 1b (right panel) shows that the highly tumorigenic cell lines, Hs578T, MDA-MB-468 and MDA-MB-231 contained the highest levels of DDX3 whereas the weakly tumorigenic cell lines, MCF-7 and SK-BR-3, and the immortalized non-tumorigenic mammary epithelial cells, MCF 10A and MCF 12A, expressed relatively low amounts of DDX3.
In addition, we analysed the DDX3 transcript levels on the same series of cell lines using quantitative realtime PCR (qRT-PCR). Figure 1c indicates that DDX3 mRNA expression increases as the tumorigenicity increases, with the highest levels observed in MDA-MB-231 cells. These results indicate that the mRNA and protein levels of DDX3 are higher in aggressive breast cancer cell lines as compared to the immortalized breast cell lines.
MCF 10A-DDX3 transgenic cells undergo an epithelialmesenchymal-like transition In an effort to identify the effects of DDX3 overexpression on cellular phenotype, we generated MCF 10A cells that stably overexpress DDX3. Stable expression of DDX3 generated distinct spindle-shaped cells rather than the normal cuboidal MCF 10A phenotype ( Figure 2a ). As shown in Figure 2b , immunofluorescence confirmed the overexpression of DDX3 in these transformants. MDA-MB-231 cells were used as a positive control for DDX3 expression. We then analysed the growth properties of these cells using Matrigel assays. As depicted in Figure 2c , the parental MCF 10A cells retained the ability to grow and spread in a contactdependent manner. On the other hand, MCF 10A-DDX3 cells exhibited a growth pattern in Matrigel that resulted in compact spherical structures, indicative of a loss of contact inhibition growth. Thus, overexpression of DDX3 in MCF 10A cells gave rise to contactindependent growth in Matrigel with the subsequent formation of dense spheroid bodies. The use of Calcein AM staining demonstrated that the dense spheroid bodies contained live cells (data not shown). A protracted incubation (4 weeks) of these plates showed that MCF 10A-DDX3 cells attained the ability to grow as individual cells rather than as colonies, indicative of contact-independent growth.
Anchorage-independent growth is another growth property of aggressive cancer cells. To test if MCF 10A-DDX3 cells can grow independent of attaching to a substratum, soft agar colony-forming assays were performed. As shown in Figure 2d , on average, MCF 10A-DDX3 cells formed 750 colonies per plate compared to only 5 colonies per plate for parental MCF 10A cells. Two independent clones were analysed that exhibited consistent results. Taken together, these results provide strong evidence that overexpression of DDX3 can alter the cellular characteristics of MCF 10A cells to that of an aggressive phenotype.
DDX3 increases motility and invasion in MCF 10A cells
One of the characteristics of epithelial-mesenchymal transition is an increase in cell motility and invasion. To test whether overexpression of DDX3 in MCF 10A cells promotes motility and invasion, cells were grown in boyden chambers in the presence of mitogen. As shown 
DDX3 alters the localization of b-catenin in breast cells
Following the observation that DDX3 induces an epithelial-mesenchymal-like transition, we performed microarray analysis, which identified E-cadherin as a downstream target gene whose expression was reduced 19-fold in MCF 10A-DDX3 cells. This reduction was verified at the protein level. As shown in Figure 4a , MCF 10A-DDX3 cells expressed little or no E-cadherin protein as compared to MCF 10A cells. As E-cadherin is associated with several cytoplasmic proteins including b-catenin, which directly interacts with E-cadherin, we compared the localization of E-cadherin and b-catenin in MCF 10A and MCF 10A-DDX3 cell lines by immunocytochemistry. As shown in Figure 4a (right panel), in MCF 10A cells, the E-cadherin (red) was predominantly localized at the cell membrane along with the majority of the b-catenin (green) staining. In both cases, this membrane-staining pattern was readily apparent at juxtaposed lateral cell-cell surface boundaries. On the other hand, in MCF 10A-DDX3 cells, there was little or no E-cadherin expression at the cell membrane (Figure 4a , right panel). In this case, b-catenin staining was diffuse with the majority being observed in the cytoplasm and to some extent in the nucleus. Merged images indicate the colocalization of E-cadherin and b-catenin (yellow-green) at the plasma membrane of MCF 10A cells, but not in MCF 10A-DDX3 cells. Similar results were obtained using two independent MCF 10A-DDX3 clones. These experiments indicate that in MCF 10A-DDX3 cells, the loss of E-cadherin at the plasma membrane results in a shift in the subcellular location of b-catenin from the membrane to the cytosol and nucleus.
DDX3 represses E-cadherin promoter-reporter activity To determine whether DDX3 transcriptionally represses E-cadherin expression, co-transfection experiments were performed in breast cancer cell lines using effector plasmid (DDX3-expressing) along with reporter constructs carrying the luciferase (Luc) gene driven by the E-cadherin promoter sequences of varying length. As shown in Figure 4b (right panel), DDX3 repressed Luc activity of the E1 and E2 construct by 8-and 14-fold, respectively. E3 and E5 constructs showed an average of two-to threefold repression of Luc activity. Thus, in this system, the most active cis-element(s) responsible for the direct or indirect regulation of the E-cadherin promoter by DDX3 is positioned between À995 and À677 bp relative to the transcription start site. Identical volumes from the final precipitate were used for PCR (except for the input chromatin, which was diluted 100 Â ). PCR was performed with primers (5 0 -CAACATGGT GAAACCCCGTCTG-3 0 , and antisense, 5 0 -GTGAGCCATGAGCCACTGAGCT-3 0 ) spanning the À893 to À641 region of the E-cadherin promoter.
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DDX3 binds to the E-cadherin promoter in vivo
To confirm that the downregulation of E-cadherin was due to the binding of DDX3 either directly or indirectly to the promoter region, we performed chromatin immunoprecipitation (ChIP) assays using MCF 10A-DDX3 cells. PCR was designed to amplify the region from À893 to À641 bp of the E-cadherin promoter, as schematically shown in Figure 4c . DNA precipitates from anti-DDX3 antibody incubation were amplified using E-cadherin promoter-specific primers (lane 4; Figure 4c ). The same was true in unprocessed chromatin as well as in anti-acetyl-histone precipitations (lanes 2 and 3 respectively; Figure 4c ). However, no amplified products were observed when either a nonspecific antibody or no antibody was used (lanes 5 and 6 respectively; Figure 4c ). These results indicate that DDX3 binds either directly or as part of a heterogeneous complex to the endogenous E-cadherin promoter.
Downregulation of DDX3 by shRNA promotes E-cadherin expression
To validate the specific regulation of E-cadherin expression by DDX3, short hairpin RNA (shRNA) clones against DDX3 were generated in MCF 10A-DDX3 cells. As shown in Figure 5a , representative clone of shRNA-DDX3 did exhibit variant colony morphology as compared to the parental clone. Analysis of DDX3 and E-cadherin protein levels clearly demonstrates the re-expression of E-cadherin in the shRNA clone (Figure 5b ). In addition, overexpression of DDX3 in another breast cancer cell, MCF-7, resulted in the decrease of E-cadherin expression (Figures 5c and d) . Taken together, these results are strong supporting evidence that indicates that DDX3 has an important function in the regulation of E-cadherin expression in these cell lines.
Regulation of tumor suppressor molecule p21Waf1/Cip1 by DDX3
Recently, Chao et al. (2006) showed that DDX3 could cause growth arrest of liver tumor cells by inducing p21 expression. However, our results indicate that DDX3 promotes anchorage-independent growth with increased motility and invasive properties. This led us to assess the functional role of DDX3 in regulating p21 expression in breast cancer cells. Initially, we performed qRT-PCR to identify the p21 mRNA expression levels in MCF 10A and two independent MCF 10A-DDX3 clones. As shown in Figure 6a (left panel), levels of p21 mRNA were reduced in the MCF 10A-DDX3 cells compared to the MCF 10A cells. Next, we performed qRT-PCR on a panel of breast cancer cell lines to correlate the expression levels of DDX3 with p21 among breast cell lines. As shown in Figure 6b , increased expression of DDX3 did not upregulate the expression of p21 in most aggressive breast cancer cell lines such as MDA-MB-231 and MDA-MB-468 as compared to MCF 10A and MCF 12A cell lines. However, an increase in p21 levels was observed in MCF-7, SK-BR-3 and Hs578T breast cancer cell lines. This is probably due to the genetic heterogeneity of the derived cell lines. Also, the stability of the mRNA and the post-transcriptional regulation may contribute to the synthesis of p21 protein levels.
Next, we performed p21 promoter-reporter assays in MCF-7 cells in the presence and absence of exogenous DDX3. As shown in Figure 6c , the use of either 2.3 or 0.16 kb p21 promoter-reporter construct did not show any increase in Luc activity in the presence of DDX3 (Zeng et al., 1997) . Thus, these results indicate that DDX3 could have divergent roles in different tumor types as aggressive breast cancer cells have relatively high levels of DDX3 and low levels of p21, which is the opposite of that reported for liver cancer. 
Discussion
Exposure to tobacco smoke is relatively common among the US population as an estimated 43% reside with at least one smoker (Pirkle et al., 1996) . However, there is conflicting evidence with respect to tobacco smoke as a causative agent in breast cancer biogenesis (Reynolds et al., 2004; Bonner et al., 2005) . To address these questions, we initiated studies to decipher the effects of tobacco smoke constituents on the growth and proliferation of breast cells. In our model, non-tumorigenic immortalized breast epithelial cells (MCF 10A) were exposed to increasing concentrations of the highly reactive metabolite of B[a]P, BPDE, a potent carcinogen found in tobacco smoke (Reynolds et al., 2004) . Exposure of MCF 10A cells to BPDE resulted in detectable changes in the growth and viability of MCF 10A cells. Under these conditions, BPDE induced a number of genes belonging to DNA damage/repair and cell-stress pathways, including the DEAD box RNA helicase, DDX3.
To characterize the function(s) of DDX3 in breast epithelial cells, we generated MCF 10A-DDX3 cells, which constitutively overexpress DDX3. MCF 10A-DDX3 cells exhibited a fibroblastic phenotype that is strikingly different from the normal epithelial-like cuboidal-shaped MCF 10A cells. Similar morphological changes are observed during an epithelial-to-mesenchymal transition, which is a hallmark of cancer progression in several types of cancers (Mironchik et al., 2005; Whitbread et al., 2006; Jung et al., 2007) Oncogenic functions of DDX3 in breast cells M Botlagunta et al soft agar. Growth on soft agar is indicative of loss of contact growth inhibition as well as a transformed phenotype (Burdick et al., 2006) . The invasive potential of MCF 10A-DDX3 cells was tested in a Matrigel-based invasion assay. The tubular networks formed by MCF 10A-DDX3 cells in Matrigel were indistinguishable from structures formed by the established aggressive breast cancer cell line MDA-MB-231. This type of invasion involves degradation of the extracellular matrix by proteolytic enzymes such as matrix metalloproteases (Yokoyama et al., 2003) . We have found that matrix metalloprotease-2 mRNA levels in MCF 10A-DDX3 cells were increased 3.6-fold relative to MCF 10A cells (data not shown). Increased levels of enzymes such as matrix metalloprotease-2 probably contribute to the increased rate of invasion of MCF 10A-DDX3 cells through Matrigel. Similarly, in motility assays, MCF 10A-DDX3 cells exhibited higher motility as compared to MCF 10A cells. The role of DDX3 in promoting aggressive phenotype was observed in two independent MCF-10A-DDX3 clones, indicating a consistent oncogenic function. The data summarized here provide strong evidence that MCF 10A-DDX3 cells gained invasive capability, which is indicative of a transformation to an aggressive phenotype.
An important characteristic of normal epithelial cells is the adhesion between cells, which is mediated in part by adherens junctions. E-cadherin is an essential component of adherens junctions and is constitutively expressed in normal epithelial cells (Takeichi, 1990) . Loss of its expression results in increased migration and proliferation of cells, leading to invasion and has been correlated to poor prognosis in the clinic (Shimoyama et al., 1989; Margulis et al., 2005) . Thus, our finding that E-cadherin was downregulated in MCF 10A-DDX3 cells relative to MCF 10A cells was an important finding that warranted further investigation. In an attempt to decipher the mechanism by which DDX3 downregulates E-cadherin expression, we performed Luc-based promoter-reporter assays, which showed that DDX3 might modulate E-cadherin expression at the transcriptional level. The transcriptional role of DDX3 is similar to that in other reports that have indicated that DEXD/DEAH box helicases can participate in the transcriptional regulation of estrogen receptor and p16INK4 (Myohanen and Baylin, 2001; Rajendran et al., 2003) . In addition, immunocytochemistry experiments indicate that a consequence of the DDX3-mediated suppression of E-cadherin is the altered subcellular localization of b-catenin from the plasma membrane to the cytosol and nucleus.
Recently, DDX3 has been shown to induce the transcriptional activity of the p21 waf1/cip1 gene via interaction with Sp1 at the promoter region and reduce cell growth and proliferation in hepatocarcinoma (Chao et al., 2006) . However, based on our data using immortalized breast cell lines and breast cancer cells, we show that DDX3 expression correlates with aggressive phenotype and does not attenuate cell growth and proliferation. It is possible that the regulatory mechanisms of DDX3 in varied cell types are different depending upon the presence of appropriate cofactors and/or signaling pathways (Marchetti et al., 1996; Myohanen and Baylin, 2001) . Also, truncating mutations of DDX3 may exist that can alter its functions in different cell types. However, based on our immunoblot data, using breast cancer cell lines, we were unable to detect any truncated version of DDX3. In addition, there was no overamplification of DDX3 (data not shown) within our panel of breast cancer cell lines (MCF 10A, MCF 10A-DDX3, MCF 12A, MCF-7, Hs578T, SK-BR-3, MDA-MB-468 and MDA-MB-231), indicating that gene amplification is probably not one of the mechanisms by which overexpression of DDX3 is accomplished. Alternative mechanisms such as increased mRNA stability or translation and decreased protein turn over could be involved in regulating the levels of DDX3.
Overall, our results indicate that the activation of DDX3 by BPDE can induce neoplastic transformation in breast cells with concomitant increase in motility and invasion. Also, overexpression of DDX3 can induce anchorage-independent growth, epithelial-mesenchymallike transition and downregulate E-cadherin expression. Finally, the broader implication of this research is that potent carcinogens found in tobacco smoke can initiate and promote breast cancer progression and one such mechanism is through the activation of DDX3, a member of DEAD box helicases.
Materials and methods
Cell culture and BPDE exposure MCF 10A cells were treated with 0.2, 0.5, 1, 1.5, 2, 2.5 or 3 mM of BPDE for 3, 10 and 24 h. Following treatment, the cells were washed, trypsinized and collected for cell viability analysis using the trypan blue exclusion assay. In a separate experiment, total RNA and proteins were isolated following BPDE induction.
Expression profile of DDX3 in breast cell lines Quantitative real-time PCR and immunoblotting were carried out to determine the expression level of DDX3 in a panel of immortalized normal breast cell lines and breast cancer cell lines. Total RNA was isolated from MCF 10A, MCF 12A, Hs578T, MCF-7, SK-BR-3, MDA-MB-468 and MDA-MB-231 cell lines using TRIzol (Invitrogen, Carlsbad, CA, USA) reagent according to the manufacturer's protocol. qRT-PCR was performed with DDX3 sense 5 0 -GGAGGAAGTACAGC CAGCAAAG-3 0 and antisense 5 0 -CTGCCAATGCCATCG TAATCACTC-3 0 primers. DDX3 protein levels were detected by immunoblots using monoclonal anti-DDX3 antibody (inhouse generated). Briefly, a bacterially expressed glutathione S-transferase-tagged full-length DDX3 fusion protein was used as antigen to generate the monoclonal antibody, which specifically recognizes the N-terminal 142 aa of DDX3.
Colony-formation assays MCF 10A or MCF 10A-DDX3 cells (1 Â 10 4 ) were suspended in 2 ml of 0.4% (wt/vol) Sea Plaque Agarose (FMC BioProducts, Rockland, ME, USA) containing Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and overlaid onto a 1% (wt/vol) Sea Plaque Agarose solution in 35-mm plates. Following incubation for 2-3 weeks, the colonies were stained with trypan blue and counted. All experiments were performed in triplicate.
Wound-healing assay Monolayers of MCF 10A and MCF 10A-DDX3 cells grown in 10 cm dishes were cleared along a diameter of the plate, with a sterile pipette tip. Cell migration was measured and photographed (using a Nikon TS100 microscope) from the wound/ scratch edge every 9 h. All experiments were performed in triplicate.
Invasion and motility assays Matrigel (100 ml; 7-8 mg ml
À1
) in serum-free medium was added to each well of a Transwell Corning Costar plate (Costar, Acton, MA, USA) and dried overnight in a tissue culture hood. The following day, 2.5 Â 10 4 cells in serum-free medium were pipetted onto the Matrigel and complete medium was added to the bottom trough. Following incubation, the transmembrane filter was stained with crystal violet and the number of cells counted. Motility assays were performed similar to the invasion assay, except that Matrigel was omitted. All experiments were performed in triplicate.
Reporter assays
Activity of the reporter gene in pGL2-Basic-E-cadherin promoter deletion constructs was assayed using the Luciferase Reporter Assay kit (Promega, Madison, WI, USA) according to the manufacturer's instructions. Reporter constructs (250 ng) were co-transfected into MCF-7 breast cancer cells (5 Â 10 4 cells) with 750 ng of pCDNA-DDX3 (effector plasmid) plus 50 ng of GFP plasmid using Trans IT-LT (Mirus, Madison, WI, USA) transfection reagent and the cells were incubated for 24 and 48 h. Following incubation, cell lysates were harvested and the luciferase activity measured (Luminometer-Berthhold Detection System, Oak Ridge, TN, USA). All experiments were performed in triplicate.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation was carried out following established protocols using the MCF 10A-DDX3 cell line as previously reported (Duriseti et al., 2006) . Chromatin-protein complexes were immunoprecipitated using monoclonal anti-DDX3 or anti-acetyl-histone antibodies. Anti-actin antibody and samples prepared without antibodies served as negative controls.
Immunofluorescence MCF 10A and MCF 10A-DDX3 (2 Â 10 4 ) were plated onto four-well chamber glass slides, fixed, permeabilized, washed and incubated for 1 h at room temperature with mouse anti-E-cadherin plus rabbit anti-b-catenin antibodies (1:1000, Transduction Laboratories, Lexington, KY, USA) followed by secondary fluorescent antibodies. Nuclei were counterstained with 4,6-diamidino-2-phenylindole and mounted with DPX (Fluka Biochemicals, Milwaukee, WI, USA), dried (4 1C, overnight) and examined using a Nikon Eclipse 80i fluorescence microscope. Images were recorded and processed with Image ProPlus 5 (Media Cybernetics) software.
Knockdown of DDX3 by shRNA
The shRNA-expressing vector was generated by cloning the annealed sense (5 0 -GATCCCCGCAAATTTGAACGTGGTG GTTCAAGAGACCACCACGTTCAAATTTGCTTTTTC-3 0 ) and antisense (5 0 -TCGAGAAAAAGCAAATTTGAACGTG GTGGTCTCTTGAACCACCACGTTCAAATTTGCGGG-3 0 ) strands into pSUPER vector. Stable shRNA clones against DDX3 were generated in MCF 10A-DDX3 cells using Trans IT-LT (Mirus) transfection reagent. Three clones of the shRNA and the MCF-7-DDX3 clones were analysed. 
